Hepatic Complications of COVID-19 and Its Treatment

Overview

Journal J Med Virol

Specialty Microbiology

Date 2020 May 22

PMID 32437004

Citations 73

Authors

Dandan Tian

Qing Ye

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19) is highly contagious and has a variety of clinical manifestations, it can affect a number of other organs in addition to the lungs, and liver injury may occur. Severe acute respiratory syndrome coronavirus 2 can cause liver injury through systemic inflammatory response syndrome, cytokine storms, ischemia-reperfusion injury, side effects of treatment drugs, and underlying liver disease and can attack liver cells directly via angiotensin-converting enzyme 2. Clinical studies have found that liver injury in COVID-19 patients mainly manifests as abnormal liver biochemical indicators, but there have been no reports of liver failure caused by this disease. The number of COVID-19 patients with liver injury is increasing, and the incidence of liver injury in COVID-19 patients with severe disease are higher than in patients with mild disease. Liver injury may be a risk factor, which worsens in patients with COVID-19, and hence it is necessary to pay attention to the occurrence of liver injury in the diagnosis and treatment of COVID-19.

Citing Articles

Hepatitis B virus associated with severe acute respiratory syndrome coronavirus 2 infection: a case report.

Florea C, Balas-Maftei B, Obreja M, Rotaru A, Irimie-Baluta E, Manciuc C J Med Case Rep. 2025; 19(1):80.

PMID: 40016849 PMC: 11869702. DOI: 10.1186/s13256-025-05085-6.

COVID-19 associated liver injury: An updated review on the mechanisms and management of risk groups.

Shi Y, Wang M, Wu L, Li X, Liao Z Liver Res. 2025; 7(3):207-215.

PMID: 39958382 PMC: 11792068. DOI: 10.1016/j.livres.2023.07.001.

Comparison of clinical, laboratory and radiological characteristics between COVID-19 and Chlamydia psittaci pneumonia: a multicenter retrospective study.

Lu R, Luo J, Lin F, Han D, Chen G, Li W Sci Rep. 2024; 14(1):23790.

PMID: 39394412 PMC: 11470005. DOI: 10.1038/s41598-024-74708-7.

Occupational exposure protection and perioperative management of sudden infectious diseases from the perspective of COVID-19.

Zhang Y, Ma R, Liu B, Zhang Q, Hai Y J Int Med Res. 2024; 52(9):3000605241266234.

PMID: 39301802 PMC: 11418532. DOI: 10.1177/03000605241266234.

Severe COVID-19 in HIV/Leishmania infantum coinfected patient: a successfully managed case report.

Farias P, Bezerra G, Neves P, Cabral L, Junior W, Guedes D BMC Infect Dis. 2024; 24(1):854.

PMID: 39174900 PMC: 11342618. DOI: 10.1186/s12879-024-09691-5.

References

Bogoch I, Watts A, Thomas-Bachli A, Huber C, Kraemer M, Khan K . Potential for global spread of a novel coronavirus from China. J Travel Med. 2020; 27(2). PMC: 7074660. DOI: 10.1093/jtm/taaa011. View

Dyson J, Hutchinson J, Harrison L, Rotimi O, Tiniakos D, Foster G . Liver toxicity associated with sofosbuvir, an NS5A inhibitor and ribavirin use. J Hepatol. 2015; 64(1):234-8. DOI: 10.1016/j.jhep.2015.07.041. View

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J . A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-733. PMC: 7092803. DOI: 10.1056/NEJMoa2001017. View

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

Mahallawi W, Khabour O, Zhang Q, Makhdoum H, Suliman B . MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine. 2018; 104:8-13. PMC: 7129230. DOI: 10.1016/j.cyto.2018.01.025. View

Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J . Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet Infect Dis. 2020; 20(4):425-434. PMC: 7159053. DOI: 10.1016/S1473-3099(20)30086-4. View

Tirado S, Yoon K . Antibody-dependent enhancement of virus infection and disease. Viral Immunol. 2003; 16(1):69-86. DOI: 10.1089/088282403763635465. View

Li X, Li X, Lu J, Huang Y, Lv L, Luan Y . Saikosaponins induced hepatotoxicity in mice via lipid metabolism dysregulation and oxidative stress: a proteomic study. BMC Complement Altern Med. 2017; 17(1):219. PMC: 5395759. DOI: 10.1186/s12906-017-1733-0. View

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

10.

Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

11.

Zhang C, Shi L, Wang F . Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020; 5(5):428-430. PMC: 7129165. DOI: 10.1016/S2468-1253(20)30057-1. View

12.

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020; 8(4):420-422. PMC: 7164771. DOI: 10.1016/S2213-2600(20)30076-X. View

13.

Mao R, Liang J, Shen J, Ghosh S, Zhu L, Yang H . Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol. 2020; 5(5):425-427. PMC: 7103943. DOI: 10.1016/S2468-1253(20)30076-5. View

14.

Guan W, Zhong N . Clinical Characteristics of Covid-19 in China. Reply. N Engl J Med. 2020; 382(19):1861-1862. DOI: 10.1056/NEJMc2005203. View

15.

Zhang Y, Zheng L, Liu L, Zhao M, Xiao J, Zhao Q . Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China. Liver Int. 2020; 40(9):2095-2103. DOI: 10.1111/liv.14455. View

16.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

17.

Bangash M, Patel J, Parekh D . COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020; 5(6):529-530. PMC: 7270582. DOI: 10.1016/S2468-1253(20)30084-4. View

18.

Lu H, Stratton C, Tang Y . Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020; 92(4):401-402. PMC: 7166628. DOI: 10.1002/jmv.25678. View

19.

Liu M, He P, Liu H, Wang X, Li F, Chen S . [Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43(0):E016. DOI: 10.3760/cma.j.issn.1001-0939.2020.0016. View

20.

Xu X, Wu X, Jiang X, Xu K, Ying L, Ma C . Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020; 368:m606. PMC: 7224340. DOI: 10.1136/bmj.m606. View